Zenas BioPharma, Inc. (ZBIO) R&D Event: Obexelimab in SLE and ZB021 Development Transcript
Zenas BioPharma, Inc. (ZBIO) R&D Event: Obexelimab in SLE and ZB021 Development October 27, 2026 8:00 AM EDTCompany ParticipantsAbigail Lee Gray -...
ZBIO
Back to marketsAdd to watchlist Oct 28, 2025 · 30.19 USDOct 28, 2026 · 28.81 USD
Zenas BioPharma, Inc.
ZBIO · NasdaqGS
$28.81+5.53%(+1.51)
Yahoo Finance · delay unknown · USD · just in
Price history
Yahoo Finance · delay unknown · USD · 5 h old
Key figures
- Previous close
- 27.30
- Day range
- 27.03 – 29.07
- Volume
- 162.5K
- Market cap
- —
Information, not investment advice.
News about Zenas BioPharma, Inc.
Finnhub · delay unknown · 1 days old
Headline and publisher summary only; full articles stay with the source.